Clinical Trial

Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in China

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to investigate and evaluate clinical performance and quality measures for adults with acute ST-elevation myocardial infarction (STEMI) in China. Further more, the investigates like to develop quality improvement strategies and relevant tools focusing on treatment and clinical outcome in patients with STEMI. This is a annually survey , through consecutively recruiting all eligible inpatients and collecting relevant medical information, the performance of all participating hospitals. Further, quality improvement strategies including summary of clinical performance and quality measures, clinical pathways and team building will be organized for the purpose of quality improvement. All hospitals will consecutively recruit qualified patients in the same method adopted in baseline period. Then the reperfusion rates and other performance measures will be compared annually.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2019-09-12.
Trial Details
NCT Number NCT04088682
Lead Sponsor China National Center for Cardiovascular Diseases
Conditions ST Elevation Myocardial Infarction
Enrollment 200,000 participants
Start Date 2018-07-15
Primary Completion 2035-12-31 (estimated)
Study Completion 2035-12-31 (estimated)
Updated on ClinicalTrials.gov 2019-10-09